Syncona
Biotech Investor · 3 portfolio companies
Portfolio
3
Combined Value
$379.3M
Focus Areas
5
Top Stage
Pre-clinical
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Autolus Therapeutics | $379.3M |
| Yellowstone Biosciences | — |
| Kesmalea Therapeutics | — |